XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Condensed Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 30, 2019   5,777      
Beginning balance at Sep. 30, 2019 $ 36,054 $ 5,777 $ 10,438 $ 33,148 $ (13,309)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 2,419     1,919 500
Performance and restricted share expense 225   225    
Share transactions under equity based plans (in shares)   139      
Share transactions under equity based plans (8) $ 139 (147)    
Ending balance (in shares) at Mar. 31, 2020   5,916      
Ending balance at Mar. 31, 2020 38,690 $ 5,916 10,516 35,067 (12,809)
Beginning balance (in shares) at Dec. 31, 2019   5,863      
Beginning balance at Dec. 31, 2019 35,245 $ 5,863 10,503 31,807 (12,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 3,379     3,260 119
Performance and restricted share expense 70   70    
Share transactions under equity based plans (in shares)   53      
Share transactions under equity based plans (4) $ 53 (57)    
Ending balance (in shares) at Mar. 31, 2020   5,916      
Ending balance at Mar. 31, 2020 38,690 $ 5,916 10,516 35,067 (12,809)
Beginning balance (in shares) at Sep. 30, 2020   5,916      
Beginning balance at Sep. 30, 2020 45,523 $ 5,916 10,736 42,339 (13,468)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 1,908     1,502 406
Performance and restricted share expense 293   293    
Share transactions under equity based plans (in shares)   73      
Share transactions under equity based plans (16) $ 73 (89)    
Ending balance (in shares) at Mar. 31, 2021   5,989      
Ending balance at Mar. 31, 2021 47,708 $ 5,989 10,940 43,841 (13,062)
Beginning balance (in shares) at Dec. 31, 2020   5,959      
Beginning balance at Dec. 31, 2020 49,141 $ 5,959 10,820 45,332 (12,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (1,583)     (1,491) (92)
Performance and restricted share expense 150   150    
Share transactions under equity based plans (in shares)   30      
Share transactions under equity based plans 0 $ 30 (30)    
Ending balance (in shares) at Mar. 31, 2021   5,989      
Ending balance at Mar. 31, 2021 $ 47,708 $ 5,989 $ 10,940 $ 43,841 $ (13,062)